Enovis Corp
and ESAB Corporation Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies to accelerate strategic momentum and unlock additional value creation potential. The Company recently announced that it expects to complete the Separation on April 4, 2022 and will then operate under the name Enovis Corporation. Enovis Corporation (NYSE: ENOV) will be an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. ESAB Corporation (NYSE: ESAB) is a world leader in fabrication and specialty gas control technology, providing its partners with advanced equipment, consumables, automation, robotics, and digital solutions which enable the everyday and extraordinary work that shapes our world.
Generated $0.1 in free cash flow for every $1 of capital expenditure in FY25.
Current Price
—
GoodMoat Value
$62.36
Enovis Corp (ENOV) Stock Analysis
ENOV Financial Charts
FCF vs CAPEX
Forward estimates use 6.9% FCF growth (CAGR)
Cash vs Debt
Net Debt: 1.3B
Revenue
3.3B
FY19
1.1B
FY20
1.4B
FY21
1.6B
FY22
1.7B
FY23
2.1B
FY24
2.2B
FY25
Net Income
—
FY19
43M
FY20
72M
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Earnings per share grew at a 50.0% CAGR.
Enovis Corp (ENOV) Financial Summary
Enovis Corp (ENOV) is a Industrials company in the Specialty Industrial Machinery industry, listed on NYSE..
..
ENOV Key Financial Metrics
| Metric | Value |
|---|
ENOV Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $3.33B | $-527.65M |
| FY20 | $1.12B | $42.63M |
| FY21 | $1.43B | $71.66M |
| FY22 | $1.56B | $-13.29M |
| FY23 | $1.71B | $-33.26M |
| FY24 | $2.11B | $-825.49M |
| FY25 | $2.25B | $-1.18B |
Enovis Corp (ENOV) Valuation
Based on GoodMoat's DCF model, Enovis Corp has a fair value estimate of $62.36.
About Enovis Corp
and ESAB Corporation Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies to accelerate strategic momentum and unlock additional value creation potential. The Company recently announced that it expects to complete the Separation on April 4, 2022 and will then operate under the name Enovis Corporation. Enovis Corporation (NYSE: ENOV) will be an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. ESAB Corporation (NYSE: ESAB) is a world leader in fabrication and specialty gas control technology, providing its partners with advanced equipment, consumables, automation, robotics, and digital solutions which enable the everyday and extraordinary work that shapes our world.